SEC ownership of ADIAL PHARMACEUTICALS, INC.

Top holders, 13D/G large-stake signals, insider positions, and transaction flow tied to CIK 0001513525.

Comparable stake leader

Coastlands Capital LP

Disclosed value leader

Coastlands Capital LP

Comparable rows

3/32

Latest evidence

17 Sep 2026

Ownership snapshot CIK-linked ownership evidence from parsed SEC filings. 3 signals
Comparable ownership rows
3 of 32
Meaning: Rows with safely comparable ownership %
Latest 13D/G holder
Coastlands Capital LP
Source: Latest parsed Schedule 13D/G stake
Latest parsed ownership date
17 Sep 2026
Freshness: Most recent filing date in this holder set
Issuer Names, identifiers, and filing context for this profile. 2 identity fields
Issuer CIK
0001513525
Issuer location
Charlottesville, VA

Ownership snapshot

Top shareholders of ADIAL PHARMACEUTICALS, INC. (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Comparable stake leader
Coastlands Capital LP
Disclosed value leader
Coastlands Capital LP
Comparable rows
3/32
Latest evidence
17 Sep 2026
13D/G 3/4/5 13F Lead comparable stake: 14% 29 rows are not safely comparable across share classes. 13D/G row: Coastlands Capital LP Showing 1-8 of 32 holder rows.

Quick read

Coastlands Capital LP leads the comparable SEC ownership view at 14%.

3 of 32 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.

Open SEC evidence Opens Coastlands Capital LP's linked filing trail.
Comparable ownership Top 3
Coastlands Capital LP 14%
ARMISTICE CAPITAL, LLC 5%
INTRACOASTAL CAPITAL, LLC 2.8%

Ownership % is shown only when SEC disclosures are safely comparable across share classes.

Detailed SEC evidence table Showing 1-8 of 32 holder rows
Holder Evidence Ownership % Position 12M Net Δ As of
Coastlands Capital LP
13D/G 3/4/5
10%+ Owner
14%
Reported 13D/G · 24 Jun 2026
$1,112,500
373,322 shares
+$331,242 24 Jun 2026
ARMISTICE CAPITAL, LLC
13D/G
5%
Reported 13D/G · 31 Mar 2026
$43,862
274,139 shares
-$404,081 31 Mar 2026
INTRACOASTAL CAPITAL, LLC
13D/G
Mitchell P. Kopin
2.8%
Reported 13D/G · 17 Jun 2025
$325,786
446,282 shares
$0 17 Jun 2025
Matt Davidson
3/4/5
Chief Development Officer, Director
—
mixed-class rows
$538,642
537,081 shares
mixed-class rows
— 11 Jun 2026
William B. Stilley III
3/4/5
Director
—
mixed-class rows
$530,200
1,311,779 shares
mixed-class rows
— 23 May 2023
Joseph Truluck
3/4/5
Chief Financial Officer
—
mixed-class rows
$111,411
290,139 shares
mixed-class rows
— 25 Mar 2024
Wendy B. Young
3/4/5
Director
—
mixed-class rows
$99,999
62,044 shares
mixed-class rows
+$99,999 17 Sep 2026
JANE STREET GROUP, LLC
13F
Company
13F
—
denominator unverified
$82,225
32,119 shares
— 30 Jun 2026
How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

Forms 3/4/5 flow

Insider trading overview

Net insider flow leans to buying over the last 12 months. Net value: +$206,328.

Buys
$206,328
Insiders: 2
Sells
$0
Insiders: 0
Net
+$206,328
Shares: +76,364
Window
Last 12 months
4 rolling buckets
Buy value Sell value
Shares: 76,364 Shares: 0
Window (months) Buy shares Sell shares Buy value Sell value Net value
0-3 0 0 $0 $0 $0
3-6 76,364 0 $206,328 $0 +$206,328
6-9 0 0 $0 $0 $0
9-12 0 0 $0 $0 $0

Reporting owners

Insider holders from Forms 3/4/5

Showing 1-13 of 13 reporting-owner rows connected to ADIAL PHARMACEUTICALS, INC.. Open a relationship link for the CIK-to-CIK filing trail.

Rows
13
Largest Forms 3/4/5 holder
Coastlands Capital LP
Net 12M change
+$206,328
Latest report
17 Sep 2026
Name Relationship Holdings Value Past Year Net Change Change % Valuation Report Date
Coastlands Capital LP 10%+ Owner $1,067,847 +$106,329 +11% Filing P/S 14 Jul 2026
Matt Davidson Chief Development Officer, Director $538,642 Mixed 11 Jun 2026
William B. Stilley III Director $530,200 Mixed 23 May 2023
Joseph Truluck Chief Financial Officer $111,411 Mixed 25 Mar 2024
Wendy B. Young Director $99,999 +$99,999 +100% Filing P/S 17 Sep 2026
Cary J. Claiborne Chief Executive Officer, Director $8,891 Mixed 07 Apr 2026
Tony Goodman Chief Operating Officer, Director $5,835 Mixed 07 Apr 2026
Vinay Shah Chief Financial Officer $3,811 Mixed 07 Apr 2026
Kevin Schuyler Director $2,076 Mixed 07 Apr 2026
Robertson H. Gilliland Director $2,020 Mixed 07 Apr 2026
J. Kermit Anderson Director Mixed 07 Apr 2026
James W. Newman Jr. Director Mixed 29 May 2025
Dr. Bankole Johnson Director Mixed 23 May 2023

Recent insider transactions for ADIAL PHARMACEUTICALS, INC.

Showing up to 300 recent insider transactions from the last 12 months.

Insider Symbol Class Transaction % SEC-reported value SEC-reported price Shares Shares owned Date Ownership
Wendy B. Young ADIL Stock Option (Right to Buy) Award 25,666 25,666 17 Sep 2026 Direct
Coastlands Capital LP ADIL Common Stock Purchase 0.32% $3,391 $2.75 1,233 388,308 16 Jul 2026 By Coastlands Capital LP
Coastlands Capital LP ADIL Common Stock Purchase 0.52% $5,300 $2.65 2,000 387,075 14 Jul 2026 By Coastlands Capital LP
Coastlands Capital LP ADIL Common Stock Purchase 0.44% $4,590 $2.70 1,700 385,075 10 Jul 2026 By Coastlands Capital LP
Coastlands Capital LP ADIL Common Stock Purchase 2.69% $28,048 $2.79 10,053 383,375 09 Jul 2026 By Coastlands Capital LP
Coastlands Capital LP ADIL Common Stock Purchase 7.18% $65,000 $2.60 25,000 373,322 29 Jun 2026 By Coastlands Capital LP
Matt Davidson ADIL Common Stock Award 357.2% 232,417 297,491 12 Jun 2026 Direct
Matt Davidson ADIL Stock Option (Right to Buy) Award 232,417 232,417 12 Jun 2026 Direct
Wendy B. Young ADIL Pre-funded Warrant Purchase $99,999 $2.75 36,378 36,378 12 Jun 2026 Direct
Matt Davidson ADIL Series A Preferred Stock Award 5.56% 101 1,923 11 Jun 2026 By Matt and Alli Davidson Trust
Matt Davidson ADIL Series A Preferred Stock Award 1,822 1,822 11 Jun 2026 Direct
Matt Davidson ADIL Common Stock Award 3,427 3,427 11 Jun 2026 By Matt and Alli Davidson Trust
Matt Davidson ADIL Common Stock Award 61,647 61,647 11 Jun 2026 Direct
Tony Goodman ADIL Common Stock Award 203923.1% 26,510 26,523 07 Apr 2026 Direct
J. Kermit Anderson ADIL Stock Option (Right to Buy) Award 9,185 9,185 07 Apr 2026 Direct
Kevin Schuyler ADIL Common Stock Award 32803.6% 9,185 9,213 07 Apr 2026 Direct
Vinay Shah ADIL Common Stock Award 17,325 17,325 07 Apr 2026 Direct
Robertson H. Gilliland ADIL Common Stock Award 9,185 9,185 07 Apr 2026 Direct
Cary J. Claiborne ADIL Common Stock Award 1561.9% 37,985 40,417 07 Apr 2026 Direct
* marks a reported price that did not pass the local price check.
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .